Are selective serotonin reuptake inhibitors associated with hepatocellular carcinoma in patients with hepatitis C? [electronic resource]
- The Journal of clinical psychiatry Oct 2014
- e1122-6 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
1555-2101
10.4088/JCP.13m08877 doi
Adult Carcinoma, Hepatocellular--chemically induced Drug Prescriptions--statistics & numerical data Hepatitis C, Chronic--drug therapy Humans Liver Neoplasms--chemically induced Male Middle Aged Registries--statistics & numerical data Selective Serotonin Reuptake Inhibitors--adverse effects United States--epidemiology United States Department of Veterans Affairs--statistics & numerical data